USD10
KYMR Shares
About Kymera TherapeuticsKymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
USD10
KYMR Shares
About Kymera TherapeuticsKymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$8.71B
OPEN PRICE
$108.19
LOW (1Y)
$55.26
HIGH (1Y)
$130.05
LOW (24H)
$104.39
HIGH (24H)
$108.59
VOLUME (24H)
$489.33K
40.4%
Price history
Time | Price | Change |
|---|---|---|
Today | $108.19 | |
1 Day | $107.49 | |
1 Week | $112.04 | |
1 Month | $119.44 | |
1 Year | $60.50 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.